LUYE PHARMA(02186) successfully included five new products in the 2025 National Medical Insurance Drug Catalog or Commercial Insurance Innovative Drug Catalog.
Green Leaf Pharmaceutical (02186) announced that a total of five new products from the group have been successfully included in the "National Essential Medicine Insurance, Maternity Insurance and Work Injury Insurance Drug List (2025)" (National Medical Insurance Drug List) or the "Commercial Health Insurance Innovation Drug List (2025)" (Commercial Health Insurance Innovation Drug List) released by the National Medical Security Administration.
LUYE PHARMA (02186) announced that the group has successfully included five new products in the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalogue (2025) (National Medical Insurance Drug Catalogue) or the Commercial Health Insurance Innovation Drug Catalogue (2025) (Commercial Health Insurance Innovation Drug Catalogue).
The five new products include: Memeixin (Hydrocodone-Naloxone Sustained-Release Tablets), Ruibailai (Paliperidone Palmitate Injection (II)) for the first time included in the National Medical Insurance Drug Catalogue; Zanbijia (Lubiprostone for Injection) successfully selected for the Commercial Health Insurance Innovation Drug Catalogue; Baituowei (Goserelin Microspheres for Injection), Ruikuotuo (Risperidone Microspheres for Injection (II)) smoothly renewed and continue to be included in the National Medical Insurance Drug Catalogue.
Related Articles
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.
CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.
GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.
CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.
GMTEight List of A-share restricted sales and lifting restrictions | December 8th
